RecruitingNCT07311356

Prognosis of Early-onset Anorexia Nervosa

Evalutation of the Prognosis and Quality of Life of Patients Hospitalized for Early-onset Anorexia Nervosa


Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

140 participants

Start Date

Dec 5, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The AM2P study aims to evaluate the long-term prognosis and quality of life of patients with early-onset anorexia nervosa, assessed 4 to 9 years after hospitalization. Prognosis will be determined using a composite outcome measure based on questionnaire responses and health indicators, including body mass index (BMI). In addition, the study will examine the patients' overall physical condition both at the time of assessment and during the interval between their last hospitalization and the present evaluation.


Eligibility

Min Age: 0 YearsMax Age: 30 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with anorexia nervosa. The study is currently recruiting participants at 1 location. People eligible for this study include aged 0 Years to 30 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Hopital Robert Debre - AP-HP

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07311356


Related Trials